Dublin, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The "Carrier Screening - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Carrier Screening Market to Reach $7.8 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Carrier Screening estimated at US$2.4 Billion in the year 2022, is projected to reach a revised size of US$7.8 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2022-2030.
Molecular Screening Test, one of the segments analyzed in the report, is projected to record 17.6% CAGR and reach US$5.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biochemical Screening Test segment is readjusted to a revised 12.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $656.9 Million, While China is Forecast to Grow at 21.5% CAGR
The Carrier Screening market in the U.S. is estimated at US$656.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 21.5% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.4% and 13.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.
Looking Ahead to 2023
Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year.
Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
What`s New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Metrics
| Report Attribute | Details |
| No. of Pages | 173 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $2.4 Billion |
| Forecasted Market Value (USD) by 2030 | $7.8 Billion |
| Compound Annual Growth Rate | 15.9% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Carrier Screening - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
FOCUS ON SELECT PLAYERS (Total 42 Featured)
- 23andMe, Inc.
- Abbott Laboratories
- AutoGenomics, Inc.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Luminex Corporation
- Myriad Genetics, Inc.
- Sequenom, Inc.
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/bu6bd9-screening?w=12
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
